INR 617.85
(-1.28%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 650.87 Million | 658.24 Million | -34.76 Million | 298.4 Million | 412.41 Million | 37.57 Million |
Net Income | 842.65 Million | 1.02 Billion | 732.98 Million | 343.25 Million | 164.72 Million | 344.52 Million |
Depreciation & Amortization | 120.52 Million | 105.47 Million | 63.78 Million | 58.99 Million | 60.06 Million | 48.48 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -275.63 Million | -234.48 Million | -643.48 Million | -24.79 Million | 214.74 Million | -274.91 Million |
Other non-cash items | 401.3 Million | -235.82 Million | -188.04 Million | -79.04 Million | -27.11 Million | -80.52 Million |
Investing Cash Flow | -199.74 Million | -431.07 Million | -241.78 Million | -147.21 Million | -144.5 Million | -70.8 Million |
Investments in PPE | -217.98 Million | -309.33 Million | -255.55 Million | -150.64 Million | -145.24 Million | -62.58 Million |
Acquisitions | 18.23 Million | -132.83 Million | 9.51 Million | 2.3 Million | 616 Thousand | -9.66 Million |
Investment purchases | - | -3 Million | - | - | - | -9.66 Million |
Sales/Maturities of investments | - | 3 Million | - | - | - | 9.66 Million |
Other Investing Activities | 11.42 Million | 11.09 Million | 4.25 Million | 1.12 Million | 119 Thousand | 1.43 Million |
Financing Cash Flow | -241.96 Million | -184.92 Million | 228.65 Million | 2.68 Million | -269.12 Million | 34.88 Million |
Debt repayment | -159.09 Million | -357.54 Million | -61.29 Million | -49.6 Million | -287.12 Million | -122.23 Million |
Dividends payments | -79.98 Million | -47.35 Million | -30.3 Million | -11.34 Million | -27.68 Million | -27.43 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -85.24 Million | 219.97 Million | 320.26 Million | 63.63 Million | 45.68 Million | 184.54 Million |
Accounts receivables | -205.27 Million | -218.16 Million | -162.57 Million | -119.08 Million | 36.17 Million | -10.24 Million |
Accounts payables | -31.97 Million | -53.17 Million | 65.15 Million | 234.2 Million | -26.33 Million | -27.45 Million |
Inventory | 40.32 Million | -66.02 Million | -447.43 Million | -196.24 Million | 187.5 Million | -286.66 Million |
Other working capital | -78.7 Million | 102.87 Million | -98.64 Million | 56.33 Million | 17.41 Million | 49.44 Million |
Cash at beginning of period | 179.04 Million | 108.69 Million | 156.57 Million | 2.7 Million | 3.91 Million | 2.25 Million |
Cash at end of period | 388.9 Million | 176.82 Million | 108.69 Million | 156.57 Million | 2.7 Million | 3.91 Million |
Capital Expenditure | -217.98 Million | -309.33 Million | -255.55 Million | -150.64 Million | -145.24 Million | -62.58 Million |
Effect of forex changes on cash | - | 25.89 Million | - | - | - | - |
Net cash flow / Change in cash | 209.85 Million | 68.13 Million | -47.88 Million | 153.87 Million | -1.2 Million | 1.65 Million |
Free Cash Flow | 432.89 Million | 348.9 Million | -290.31 Million | 147.75 Million | 267.17 Million | -25 Million |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 178.21 Million | 256.8 Million | 842.65 Million | 169.61 Million | 203.42 Million | 212.81 Million |
Depreciation & Amortization | - | - | 120.52 Million | 30.97 Million | 29.22 Million | 29.35 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | -275.63 Million | - | - | - |
Other non-cash items | -178.21 Million | -256.8 Million | 401.3 Million | -169.61 Million | -203.42 Million | -212.81 Million |
Investing Cash Flow | - | - | -199.74 Million | - | - | - |
Investments in PPE | - | - | -217.98 Million | - | - | - |
Acquisitions | - | - | 18.23 Million | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | 11.42 Million | - | - | - |
Financing Cash Flow | - | - | -241.96 Million | - | - | - |
Debt repayment | - | - | -159.09 Million | - | - | - |
Dividends payments | - | - | -79.98 Million | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | -85.24 Million | - | - | - |
Accounts receivables | - | - | -205.27 Million | - | - | - |
Accounts payables | - | - | -31.97 Million | - | - | - |
Inventory | - | - | 40.32 Million | - | - | - |
Other working capital | - | - | -78.7 Million | - | - | - |
Cash at beginning of period | - | - | 179.04 Million | 324.38 Million | 265.94 Million | 179.04 Million |
Cash at end of period | - | - | 388.9 Million | 386.33 Million | 324.38 Million | 237.76 Million |
Capital Expenditure | - | - | -217.98 Million | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | 209.85 Million | 61.95 Million | 58.44 Million | 58.71 Million |
Free Cash Flow | - | - | 432.89 Million | 61.95 Million | 58.44 Million | 58.71 Million |
OATN
JINFF
603527
UNICHEMLAB
KUKE
CRGY